{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:01:52Z","timestamp":1791273712625,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/leu.2011.378","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T12:40:24Z","timestamp":1324557624000},"page":"1383-1390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["BCL2 mutations in diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"26","author":[{"given":"J M","family":"Schuetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N A","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D W","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ben-Nierah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G W","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A R","family":"Brooks-Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"key":"BFleu2011378_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC: Lyon, France, 2008."},{"key":"BFleu2011378_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503\u2013511.","journal-title":"Nature"},{"key":"BFleu2011378_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.6093263","volume":"226","author":"Y Tsujimoto","year":"1984","unstructured":"Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM . Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226: 1097\u20131099.","journal-title":"Science"},{"key":"BFleu2011378_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/335440a0","volume":"335","author":"DL Vaux","year":"1988","unstructured":"Vaux DL, Cory S, Adams JM . Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440\u2013442.","journal-title":"Nature"},{"key":"BFleu2011378_CR5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V96.3.808","volume":"96","author":"TG Willis","year":"2000","unstructured":"Willis TG, Dyer MJ . The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000; 96: 808\u2013822.","journal-title":"Blood"},{"key":"BFleu2011378_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0002-9440(10)63284-1","volume":"165","author":"J Iqbal","year":"2004","unstructured":"Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 2004; 165: 159\u2013166.","journal-title":"Am J Pathol"},{"key":"BFleu2011378_CR7","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/JCO.2005.03.4264","volume":"24","author":"J Iqbal","year":"2006","unstructured":"Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A et al. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 961\u2013968.","journal-title":"J Clin Oncol"},{"key":"BFleu2011378_CR8","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.1073\/pnas.0903854106","volume":"106","author":"M Saito","year":"2009","unstructured":"Saito M, Novak U, Piovan E, Basso K, Sumazin P, Schneider C et al. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2009; 106: 11294\u201311299.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011378_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3109\/00313021003631296","volume":"42","author":"N Masir","year":"2010","unstructured":"Masir N, Campbell LJ, Jones M, Mason DY . Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody. Pathology 2010; 42: 212\u2013216.","journal-title":"Pathology"},{"key":"BFleu2011378_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/path.1689","volume":"205","author":"M Schraders","year":"2005","unstructured":"Schraders M, de Jong D, Kluin P, Groenen P, van Krieken H . Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol 2005; 205: 329\u2013335.","journal-title":"J Pathol"},{"key":"BFleu2011378_CR11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood.V87.1.265.265","volume":"87","author":"O Hermine","year":"1996","unstructured":"Hermine O, Haioun C, Lepage E, d\u2019Agay MF, Briere J, Lavignac C et al. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA). Blood 1996; 87: 265\u2013272.","journal-title":"Blood"},{"key":"BFleu2011378_CR12","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1182\/blood-2002-11-3442","volume":"101","author":"N Mounier","year":"2003","unstructured":"Mounier N, Briere J, Gisselbrecht C, Emile JF, Lederlin P, Sebban C et al. Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood 2003; 101: 4279\u20134284.","journal-title":"Blood"},{"key":"BFleu2011378_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.2298\/VSP0909738P","volume":"66","author":"MP Jovanovic","year":"2009","unstructured":"Jovanovic MP, Jakovic L, Bogdanovic A, Markovic O, Martinovic VC, Mihaljevic B . Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells. Vojnosanit Pregl 2009; 66: 738\u2013743.","journal-title":"Vojnosanit Pregl"},{"key":"BFleu2011378_CR14","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1158\/1078-0432.CCR-11-0267","volume":"17","author":"J Iqbal","year":"2011","unstructured":"Iqbal J, Meyer PN, Smith L, Johnson NA, Vose JM, Greiner TC et al. BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and Rituximab. Clin Cancer Res 2011; 17: 7785\u20137795.","journal-title":"Clin Cancer Res"},{"key":"BFleu2011378_CR15","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1016\/j.febslet.2005.05.015","volume":"579","author":"GU Gurudutta","year":"2005","unstructured":"Gurudutta GU, Verma YK, Singh VK, Gupta P, Raj HG, Sharma RK et al. Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins. FEBS Lett 2005; 579: 3503\u20133507.","journal-title":"FEBS Lett"},{"key":"BFleu2011378_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.275.5302.983","volume":"275","author":"M Sattler","year":"1997","unstructured":"Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 1997; 275: 983\u2013986.","journal-title":"Science"},{"key":"BFleu2011378_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B . Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008; 5: 621\u2013628.","journal-title":"Nat Methods"},{"key":"BFleu2011378_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010; 42: 181\u2013185.","journal-title":"Nat Genet"},{"key":"BFleu2011378_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298\u2013303.","journal-title":"Nature"},{"key":"BFleu2011378_CR20","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","volume":"114","author":"KJ Savage","year":"2009","unstructured":"Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P et al. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 2009; 114: 3533\u20133537.","journal-title":"Blood"},{"key":"BFleu2011378_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3324\/haematol.2009.007203","volume":"95","author":"J Shustik","year":"2010","unstructured":"Shustik J, Han G, Farinha P, Johnson NA, Ben Neriah S, Connors JM et al. Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP. Haematologica 2010; 95: 96\u2013101.","journal-title":"Haematologica"},{"key":"BFleu2011378_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275\u2013282.","journal-title":"Blood"},{"key":"BFleu2011378_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/gcc.1103","volume":"30","author":"DE Horsman","year":"2001","unstructured":"Horsman DE, Connors JM, Pantzar T, Gascoyne RD . Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001; 30: 375\u2013382.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2011378_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cancergencyto.2004.05.012","volume":"157","author":"G Bentley","year":"2005","unstructured":"Bentley G, Palutke M, Mohamed AN . Variant t(14;18) in malignant lymphoma: a report of seven cases. Cancer Genet Cytogenet 2005; 157: 12\u201317.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFleu2011378_CR25","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754\u20131760.","journal-title":"Bioinformatics"},{"key":"BFleu2011378_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/bioinformatics\/btq040","volume":"26","author":"R Goya","year":"2010","unstructured":"Goya R, Sun MG, Morin RD, Leung G, Ha G, Wiegand KC et al. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 2010; 26: 730\u2013736.","journal-title":"Bioinformatics"},{"key":"BFleu2011378_CR27","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365\u2013386.","journal-title":"Methods Mol Biol"},{"key":"BFleu2011378_CR28","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1093\/nar\/gkf493","volume":"30","author":"V Ramensky","year":"2002","unstructured":"Ramensky V, Bork P, Sunyaev S . Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002; 30: 3894\u20133900.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2011378_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/35085588","volume":"412","author":"L Pasqualucci","year":"2001","unstructured":"Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341\u2013346.","journal-title":"Nature"},{"key":"BFleu2011378_CR30","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.4049\/jimmunol.146.9.3218","volume":"146","author":"JS Weber","year":"1991","unstructured":"Weber JS, Berry J, Litwin S, Claflin JL . Somatic hypermutation of the JC intron is markedly reduced in unrearranged kappa and H alleles and is unevenly distributed in rearranged alleles. J Immunol 1991; 146: 3218\u20133226.","journal-title":"J Immunol"},{"key":"BFleu2011378_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.immunol.26.021607.090236","volume":"26","author":"JU Peled","year":"2008","unstructured":"Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF et al. The biochemistry of somatic hypermutation. Annu Rev Immunol 2008; 26: 481\u2013511.","journal-title":"Annu Rev Immunol"},{"key":"BFleu2011378_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V79.1.229.229","volume":"79","author":"S Tanaka","year":"1992","unstructured":"Tanaka S, Louie DC, Kant JA, Reed JC . Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas. Blood 1992; 79: 229\u2013237.","journal-title":"Blood"},{"key":"BFleu2011378_CR33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature06547","volume":"451","author":"M Liu","year":"2008","unstructured":"Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, Kleinstein SH et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008; 451: 841\u2013845.","journal-title":"Nature"},{"key":"BFleu2011378_CR34","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1128\/MCB.01647-05","volume":"26","author":"X Deng","year":"2006","unstructured":"Deng X, Gao F, Flagg T, Anderson J, May WS . Bcl2's flexible loop domain regulates p53 binding and survival. Mol Cell Biol 2006; 26: 4421\u20134434.","journal-title":"Mol Cell Biol"},{"key":"BFleu2011378_CR35","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1126\/science.278.5345.1966","volume":"278","author":"EH Cheng","year":"1997","unstructured":"Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278: 1966\u20131968.","journal-title":"Science"},{"key":"BFleu2011378_CR36","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/emboj\/17.5.1268","volume":"17","author":"D Grandgirard","year":"1998","unstructured":"Grandgirard D, Studer E, Monney L, Belser T, Fellay I, Borner C et al. Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J 1998; 17: 1268\u20131278.","journal-title":"EMBO J"},{"key":"BFleu2011378_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0092-8674(04)00162-X","volume":"116","author":"B Lin","year":"2004","unstructured":"Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77\/TR3. Cell 2004; 116: 527\u2013540.","journal-title":"Cell"},{"key":"BFleu2011378_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ccr.2007.07.001","volume":"12","author":"J Deng","year":"2007","unstructured":"Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A . BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 2007; 12: 171\u2013185.","journal-title":"Cancer Cell"},{"key":"BFleu2011378_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/j.1460-2075.1988.tb02791.x","volume":"7","author":"M Seto","year":"1988","unstructured":"Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P et al. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J 1988; 7: 123\u2013131.","journal-title":"EMBO J"},{"issue":"Suppl 3","key":"BFleu2011378_CR40","first-page":"15S","volume":"6","author":"S Tanaka","year":"1992","unstructured":"Tanaka S, Louie D, Kant J, Reed JC . Application of a PCR-mismatch technique to the BCL-2 gene: detection of point mutations in BCL-2 genes of malignancies with A t(14,18). Leukemia 1992; 6 (Suppl 3): 15S\u201319S.","journal-title":"Leukemia"},{"key":"BFleu2011378_CR41","first-page":"481","volume":"11","author":"VI Pappa","year":"1997","unstructured":"Pappa VI, Wilkes S, Norton A, Phillips S, Rohatiner AZS, Lister TA et al. Detection of somatic mutations of the bcl-2 oncogene in B cell lymphomas with the t(14;18). Int J Oncol 1997; 11: 481\u2013488.","journal-title":"Int J Oncol"},{"key":"BFleu2011378_CR42","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/emboj\/16.5.968","volume":"16","author":"BS Chang","year":"1997","unstructured":"Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB . Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J 1997; 16: 968\u2013977.","journal-title":"EMBO J"},{"key":"BFleu2011378_CR43","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1073\/pnas.96.7.3775","volume":"96","author":"RK Srivastava","year":"1999","unstructured":"Srivastava RK, Mi QS, Hardwick JM, Longo DL . Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci USA 1999; 96: 3775\u20133780.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011378_CR44","first-page":"2506","volume":"56","author":"EJ Uhlmann","year":"1996","unstructured":"Uhlmann EJ, D\u2019Sa-Eipper C, Subramanian T, Wagner AJ, Hay N, Chinnadurai G . Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res 1996; 56: 2506\u20132509.","journal-title":"Cancer Res"},{"key":"BFleu2011378_CR45","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1084\/jem.183.5.2219","volume":"183","author":"S Mazel","year":"1996","unstructured":"Mazel S, Burtrum D, Petrie HT . Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 1996; 183: 2219\u20132226.","journal-title":"J Exp Med"},{"key":"BFleu2011378_CR46","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1002\/j.1460-2075.1996.tb01090.x","volume":"15","author":"LA O\u2019Reilly","year":"1996","unstructured":"O\u2019Reilly LA, Huang DC, Strasser A . The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 1996; 15: 6979\u20136990.","journal-title":"EMBO J"},{"key":"BFleu2011378_CR47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s004390050847","volume":"103","author":"S Komaki","year":"1998","unstructured":"Komaki S, Kohno M, Matsuura N, Shimadzu M, Adachi N, Hoshide R et al. The polymorphic 43Thr bcl-2 protein confers relative resistance to autoimmunity: an analytical evaluation. Hum Genet 1998; 103: 435\u2013440.","journal-title":"Hum Genet"},{"key":"BFleu2011378_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0014-5793(04)00059-6","volume":"559","author":"AM Petros","year":"2004","unstructured":"Petros AM, Gunasekera A, Xu N, Olejniczak ET, Fesik SW . Defining the p53 DNA-binding domain\/Bcl-x(L)-binding interface using NMR. FEBS Lett 2004; 559: 171\u2013174.","journal-title":"FEBS Lett"},{"key":"BFleu2011378_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1073\/pnas.2533920100","volume":"101","author":"X Deng","year":"2004","unstructured":"Deng X, Gao F, Flagg T, May Jr WS . Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions. Proc Natl Acad Sci USA 2004; 101: 153\u2013158.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011378_CR50","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.molcel.2008.06.001","volume":"30","author":"Y Wei","year":"2008","unstructured":"Wei Y, Pattingre S, Sinha S, Bassik M, Levine B . JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 2008; 30: 678\u2013688.","journal-title":"Mol Cell"},{"key":"BFleu2011378_CR51","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1182\/blood-2003-04-1027","volume":"102","author":"X Deng","year":"2003","unstructured":"Deng X, Gao F, May Jr WS . Bcl2 retards G1\/S cell cycle transition by regulating intracellular ROS. Blood 2003; 102: 3179\u20133185.","journal-title":"Blood"},{"key":"BFleu2011378_CR52","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/cdd.2008.25","volume":"15","author":"M Vogler","year":"2008","unstructured":"Vogler M, Dinsdale D, Sun XM, Young KW, Butterworth M, Nicotera P et al. A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells. Cell Death Differ 2008; 15: 820\u2013830.","journal-title":"Cell Death Differ"},{"key":"BFleu2011378_CR53","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/sj.cdd.4401960","volume":"13","author":"P Pinton","year":"2006","unstructured":"Pinton P, Rizzuto R . Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 2006; 13: 1409\u20131418.","journal-title":"Cell Death Differ"},{"key":"BFleu2011378_CR54","doi-asserted-by":"publisher","first-page":"8600","DOI":"10.1074\/jbc.M507611200","volume":"281","author":"Y Tomita","year":"2006","unstructured":"Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, Klein C et al. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem 2006; 281: 8600\u20138606.","journal-title":"J Biol Chem"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011378","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T02:28:03Z","timestamp":1686536883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFleu2011378"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.378","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]},"assertion":[{"value":"12 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}